159 related articles for article (PubMed ID: 2661820)
1. Renin inhibitors. Synthesis of transition-state analogue inhibitors containing phosphorus acid derivatives at the scissile bond.
Allen MC; Fuhrer W; Tuck B; Wade R; Wood JM
J Med Chem; 1989 Jul; 32(7):1652-61. PubMed ID: 2661820
[TBL] [Abstract][Full Text] [Related]
2. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
[TBL] [Abstract][Full Text] [Related]
3. Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.
Boger J; Payne LS; Perlow DS; Lohr NS; Poe M; Blaine EH; Ulm EH; Schorn TW; LaMont BI; Lin TY
J Med Chem; 1985 Dec; 28(12):1779-90. PubMed ID: 3906131
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and renin inhibitory activity of angiotensinogen analogues having dehydrostatine, Leu psi [CH2S]Val, or Leu psi [CH2SO]Val at the P1-P1' cleavage site.
Smith CW; Saneii HH; Sawyer TK; Pals DT; Scahill TA; Kamdar BV; Lawson JA
J Med Chem; 1988 Jul; 31(7):1377-82. PubMed ID: 3290486
[TBL] [Abstract][Full Text] [Related]
5. Potent in vivo inhibitors of rat renin: analogues of human and rat angiotensinogen sequences containing different classes of pseudodipeptides at the scissile site.
Sueiras-Diaz J; Jones DM; Szelke M; Leckie BJ; Beattie SR; Beattie C; Morton JJ
J Pept Res; 1997 Oct; 50(4):239-47. PubMed ID: 9352462
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of some transition-state inhibitors of human renin.
Bühlmayer P; Caselli A; Fuhrer W; Göschke R; Rasetti V; Rüeger H; Stanton JL; Criscione L; Wood JM
J Med Chem; 1988 Sep; 31(9):1839-46. PubMed ID: 3137345
[TBL] [Abstract][Full Text] [Related]
7. Renin inhibitors containing psi[CH2O] pseudopeptide inserts.
TenBrink RE; Pals DT; Harris DW; Johnson GA
J Med Chem; 1988 Mar; 31(3):671-7. PubMed ID: 3279210
[TBL] [Abstract][Full Text] [Related]
8. Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a dihydroxyethylene transition-state mimic at the scissile bond to impart greater inhibitory potency.
Luly JR; BaMaung N; Soderquist J; Fung AK; Stein H; Kleinert HD; Marcotte PA; Egan DA; Bopp B; Merits I
J Med Chem; 1988 Dec; 31(12):2264-76. PubMed ID: 3143009
[TBL] [Abstract][Full Text] [Related]
9. New renin inhibitors containing novel analogues of statine.
Jones DM; Sueiras-Diaz J; Szelke M; Leckie BJ; Beattie SR; Morton J; Neidle S; Kuroda R
J Pept Res; 1997 Aug; 50(2):109-21. PubMed ID: 9273895
[TBL] [Abstract][Full Text] [Related]
10. New inhibitors of human renin that contain novel Leu-Val replacements. Examination of the P1 site.
Luly JR; Bolis G; BaMaung N; Soderquist J; Dellaria JF; Stein H; Cohen J; Perun TJ; Greer J; Plattner JJ
J Med Chem; 1988 Mar; 31(3):532-9. PubMed ID: 3279206
[TBL] [Abstract][Full Text] [Related]
11. Renin inhibitors. Dipeptide analogues of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bond.
Bolis G; Fung AK; Greer J; Kleinert HD; Marcotte PA; Perun TJ; Plattner JJ; Stein HH
J Med Chem; 1987 Oct; 30(10):1729-37. PubMed ID: 3309313
[TBL] [Abstract][Full Text] [Related]
12. Design of rat renin inhibitory peptides.
Hui KY; Holtzman EJ; Quinones MA; Hollenberg NK; Haber E
J Med Chem; 1988 Sep; 31(9):1679-86. PubMed ID: 3045320
[TBL] [Abstract][Full Text] [Related]
13. New inhibitors of human renin that contain novel Leu-Val replacements.
Luly JR; Yi N; Soderquist J; Stein H; Cohen J; Perun TJ; Plattner JJ
J Med Chem; 1987 Sep; 30(9):1609-16. PubMed ID: 3305946
[TBL] [Abstract][Full Text] [Related]
14. Renin inhibitors. Design of angiotensinogen transition-state analogues containing novel. (2R,3R,4R,5S)-5-amino-3,4-dihydroxy-2-isopropyl-7-methyloctanoic acid.
Thaisrivongs S; Pals DT; Kroll LT; Turner SR; Han FS
J Med Chem; 1987 Jun; 30(6):976-82. PubMed ID: 3295239
[TBL] [Abstract][Full Text] [Related]
15. The His-Pro-Phe motif of angiotensinogen is a crucial determinant of the substrate specificity of renin.
Nakagawa T; Akaki J; Satou R; Takaya M; Iwata H; Katsurada A; Nishiuchi K; Ohmura Y; Suzuki F; Nakamura Y
Biol Chem; 2007 Feb; 388(2):237-46. PubMed ID: 17261087
[TBL] [Abstract][Full Text] [Related]
16. Design of potent substrate-analogue inhibitors of canine renin.
Hui KY; Siragy HM; Haber E
Int J Pept Protein Res; 1992 Aug; 40(2):152-60. PubMed ID: 1446972
[TBL] [Abstract][Full Text] [Related]
17. Highly potent and specific inhibitors of human renin.
Sham HL; Stein H; Rempel CA; Cohen J; Plattner JJ
FEBS Lett; 1987 Aug; 220(2):299-301. PubMed ID: 3111889
[TBL] [Abstract][Full Text] [Related]
18. Crystallographic studies of reduced bond inhibitors complexed with an aspartic proteinase.
Foundling SI; Cooper J; Watson FE; Pearl LH; Hemmings A; Wood SP; Blundell T; Hallett A; Jones DM; Sueiras J
J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S59-68. PubMed ID: 2485065
[TBL] [Abstract][Full Text] [Related]
19. New inhibitors of human renin tested in vitro and in vivo in the anaesthetized baboon.
Tree M; Atrash B; Donovan B; Gamble J; Hallett A; Hughes M; Jones DM; Leckie B; Lever AF; Morton JJ
J Hypertens; 1983 Dec; 1(4):399-403. PubMed ID: 6398331
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of human angiotensinogen (1-17) containing one of the putative glycosylation binding sites and its hydrolysis by human renin and porcine pepsin.
Hirata IY; Boschcov P; Oliveira MC; Juliano MA; Miranda A; Chagas JR; Tsuboi S; Okada Y; Juliano L
Int J Pept Protein Res; 1991 Oct; 38(4):298-307. PubMed ID: 1797705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
